Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003555978 | SCV004298064 | pathogenic | not provided | 2023-09-27 | criteria provided, single submitter | clinical testing | This sequence change replaces leucine, which is neutral and non-polar, with proline, which is neutral and non-polar, at codon 441 of the GDF5 protein (p.Leu441Pro). For these reasons, this variant has been classified as Pathogenic. Experimental studies have shown that this missense change affects GDF5 function (PMID: 16127465, 21976273). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt GDF5 protein function. ClinVar contains an entry for this variant (Variation ID: 8381). This variant is also known as L60P. This missense change has been observed in individuals with GDF5-related conditions (PMID: 12121354, 16014698). It has also been observed to segregate with disease in related individuals. This variant is not present in population databases (gnomAD no frequency). |
OMIM | RCV000008887 | SCV000029097 | pathogenic | Acromesomelic dysplasia 2B | 2006-03-01 | no assertion criteria provided | literature only | |
OMIM | RCV000008888 | SCV000029098 | pathogenic | Type A2 brachydactyly | 2006-03-01 | no assertion criteria provided | literature only | |
Clinical Genetics Laboratory, |
RCV001770033 | SCV002011717 | likely pathogenic | Symphalangism, proximal, 1B | 2021-09-23 | no assertion criteria provided | clinical testing |